NDRA
ENDRA Life Sciences Inc.Company with tickers: NDRA
CIK
1681682
CUSIP
29273B500
Shares Outstanding
1,848,464
13F Activity (30d)
3 filings
3 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-28 | 2026-05-27 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-04-21 | 2026-04-20 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-25 | 2026-03-19 | |
| 8-K | 2025-12-15 | 2025-12-09 | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-10-30 | 2025-10-29 | |
| DEF 14A | 2025-10-28 | 2024-12-31 | |
| 8-K | 2025-10-23 | — | |
| 8-K/A | 2025-10-15 | 2025-10-10 | |
| 8-K | 2025-10-15 | 2025-10-10 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-05-30 | 2025-05-27 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 10-K/A | 2025-04-07 | 2024-12-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2024-11-22 | — | |
| 10-Q/A | 2024-11-21 | 2024-09-30 | |
| 10-Q | 2024-11-19 | 2024-09-30 | |
| 8-K | 2024-11-15 | — | |
| 8-K | 2024-11-05 | 2024-11-04 | |
| 8-K | 2024-10-29 | 2024-10-28 | |
| DEF 14A | 2024-09-16 | 2024-09-06 | |
| 8-K | 2024-08-28 | — | |
| 8-K | 2024-08-23 | 2024-08-22 | |
| 8-K | 2024-08-16 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-13 | 2024-08-12 | |
| 8-K | 2024-08-09 | 2024-08-05 | |
| 8-K | 2024-07-17 | 2024-07-15 | |
| DEF 14A | 2024-06-25 | 2024-08-06 | |
| 8-K | 2024-06-06 | 2024-06-04 | |
| 8-K | 2024-05-20 | — | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-10 | — | |
| 8-K | 2024-05-03 | — | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 |
Showing 1–50 of 126 filings